Compounds > amantadine
Page last updated: 2024-10-22

amantadine and Catatonia

amantadine has been researched along with Catatonia in 26 studies

amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source

Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)

Research Excerpts

ExcerptRelevanceReference
" This case demonstrates the safe use of memantine as an adjunctive agent in an adolescent with catatonia."5.72Safe Use of Memantine in a Pediatric Patient With Catatonia. ( Chaffkin, J; Josephs, IA; Katz, ER, 2022)
"Amantadine, which was originally developed as an antiviral medication, functions as a dopamine agonist in the central nervous system and consequently is utilized in the treatment of Parkinson disease, drug-induced extrapyramidal reactions, and neuroleptic malignant syndrome."3.85The Role of Amantadine Withdrawal in 3 Cases of Treatment-Refractory Altered Mental Status. ( Fox, J; Fryml, LD; Pelic, CG; Revuelta, GJ; Robert, S; Sahlem, G; Short, EB; Williams, KR, 2017)
"This article presents a case of a 14-year-old female twin with schizophrenia who developed severe catatonia following treatment with olanzapine."3.79A case of catatonia in a 14-year-old girl with schizophrenia treated with electroconvulsive therapy. ( Buchmann, J; Häßler, F; Höppner, J; Pohl, B; Reis, O; Weirich, S, 2013)
"Sequential therapeutic trials for catatonoid frontal signs in clinically-evident frontotemporal dementia (n = 2) revealed differential benefits for lorazepam, amantadine, memantine, pramipexole, aripiprazole, quetiapine, citalopram, and donepezil, although certain signs also worsened."3.76Differential pharmacological responses of catatonia-like signs in frontotemporal dementia. ( Greenway, LL; Kuppuswamy, PS; Lauterbach, EC, 2010)
"Her maximum score on the Bush-Francis Catatonia Rating Scale (BFCRS) was 15/69 on day 2 of her stay."1.91Celiac disease and catatonia: more than a coincidence? ( Gücüyener, K; Karaduman, AE; Menderes, DK; Özbudak, P; Öztürk, H, 2023)
" This case demonstrates the safe use of memantine as an adjunctive agent in an adolescent with catatonia."1.72Safe Use of Memantine in a Pediatric Patient With Catatonia. ( Chaffkin, J; Josephs, IA; Katz, ER, 2022)
"Although neurological manifestations of typhoid fever was thought to be obsolete from modern world, emergence of multidrug resistant typhoid bacilli and reporting of outbreak of typhoid fever with a range of early neuropsychiatric manifestations from various parts of world has led clinicians and investigators to re-evaluate the clinical spectrum of this endemic sinister disease."1.39Catatonia and parkinsonism as a sequelae of typhoid fever: a rare experience. ( Dutta, A; Rana, S; Talukdar, A; Talukdar, P, 2013)
"Catatonia is an underdiagnosed psychomotor syndrome often associated with neurological and psychiatric disorders, but it has rarely been documented in patients with HD."1.37Westphal variant Huntington disease and refractory catatonia: a case report. ( Aguilar-Venegas, LC; Espinola-Nadurille, M; Fricchione, GL; Merida-Puga, J; Ramirez-Bermudez, J, 2011)

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19907 (26.92)18.7374
1990's2 (7.69)18.2507
2000's1 (3.85)29.6817
2010's12 (46.15)24.3611
2020's4 (15.38)2.80

Authors

AuthorsStudies
Rengasamy, ER1
Rogers, JP1
Chaffkin, J1
Josephs, IA1
Katz, ER1
Oh, J3
Amber-Monta, K3
Sahota, PC3
Pradhan, BK3
Koola, MM3
Özbudak, P1
Karaduman, AE1
Menderes, DK1
Öztürk, H1
Gücüyener, K1
Fryml, LD1
Williams, KR1
Pelic, CG1
Fox, J1
Sahlem, G1
Robert, S1
Revuelta, GJ1
Short, EB1
Chen, CW1
Lin, SH1
Huang, LC1
Yang, YK1
Hervey, WM1
Stewart, JT1
Catalano, G1
Goetz, M1
Kitzlerova, E1
Hrdlicka, M1
Dhossche, D1
Talukdar, P1
Dutta, A1
Rana, S1
Talukdar, A1
Ene-Stroescu, V2
Nguyen, T2
Waiblinger, BE2
Ellul, P1
Rotgé, JY1
Choucha, W1
Lauterbach, EC1
Kuppuswamy, PS1
Greenway, LL1
Merida-Puga, J1
Ramirez-Bermudez, J1
Aguilar-Venegas, LC1
Fricchione, GL1
Espinola-Nadurille, M1
de Lucena, DF1
Pinto, JP1
Hallak, JE1
Crippa, JA1
Gama, CS1
Häßler, F1
Reis, O1
Weirich, S1
Höppner, J1
Pohl, B1
Buchmann, J1
Goforth, H1
West, AP1
Northoff, G2
Eckert, J1
Fritze, J1
Lins, H1
Böker, H1
Danos, P1
Bogerts, B1
Chopra, YM1
Dandiya, PC1
Gelenberg, AJ1
Mandel, MR1
Guzé, BH1
Baxter, LR1
Kamianov, IM1
Kupisk, AG1
Katsen, IZ1
Poignant, JC1
Gressier, H1
Malecot, E1
Mori, J1
Sato, Y1
Oashi, T1
Hitomi, M1

Reviews

1 review available for amantadine and Catatonia

ArticleYear
Current concepts. Neuroleptic malignant syndrome.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Amantadine; Basal Ganglia Diseases; Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; D

1985

Other Studies

25 other studies available for amantadine and Catatonia

ArticleYear
The use of amantadine in catatonia.
    The Lancet. Neurology, 2022, Volume: 21, Issue:6

    Topics: Amantadine; Catatonia; Humans

2022
Safe Use of Memantine in a Pediatric Patient With Catatonia.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2022, Volume: 61, Issue:12

    Topics: Adolescent; Amantadine; Benzodiazepines; Catatonia; Electroconvulsive Therapy; Humans; Memantine

2022
COVID-19-Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine.
    The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6

    Topics: Amantadine; Benzodiazepines; Catatonia; COVID-19; Electroconvulsive Therapy; Humans

2022
COVID-19-Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine.
    The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6

    Topics: Amantadine; Benzodiazepines; Catatonia; COVID-19; Electroconvulsive Therapy; Humans

2022
COVID-19-Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine.
    The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6

    Topics: Amantadine; Benzodiazepines; Catatonia; COVID-19; Electroconvulsive Therapy; Humans

2022
COVID-19-Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine.
    The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6

    Topics: Amantadine; Benzodiazepines; Catatonia; COVID-19; Electroconvulsive Therapy; Humans

2022
COVID-19-Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine.
    The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6

    Topics: Amantadine; Benzodiazepines; Catatonia; COVID-19; Electroconvulsive Therapy; Humans

2022
COVID-19-Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine.
    The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6

    Topics: Amantadine; Benzodiazepines; Catatonia; COVID-19; Electroconvulsive Therapy; Humans

2022
COVID-19-Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine.
    The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6

    Topics: Amantadine; Benzodiazepines; Catatonia; COVID-19; Electroconvulsive Therapy; Humans

2022
COVID-19-Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine.
    The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6

    Topics: Amantadine; Benzodiazepines; Catatonia; COVID-19; Electroconvulsive Therapy; Humans

2022
COVID-19-Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine.
    The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6

    Topics: Amantadine; Benzodiazepines; Catatonia; COVID-19; Electroconvulsive Therapy; Humans

2022
Celiac disease and catatonia: more than a coincidence?
    The Turkish journal of pediatrics, 2023, Volume: 65, Issue:1

    Topics: Adolescent; Amantadine; Biopsy; Catatonia; Celiac Disease; Child; Diazepam; Female; Humans

2023
The Role of Amantadine Withdrawal in 3 Cases of Treatment-Refractory Altered Mental Status.
    Journal of psychiatric practice, 2017, Volume: 23, Issue:3

    Topics: Aged; Amantadine; Catatonia; Delirium; Dopamine Agents; Electroconvulsive Therapy; Humans; Male; Mid

2017
Transcranial direct current stimulation (tDCS) improved psychomotor slowness and decreased catatonia in a patient with schizophrenia: Case report.
    The Kaohsiung journal of medical sciences, 2018, Volume: 34, Issue:6

    Topics: Adult; Amantadine; Antipsychotic Agents; Bupropion; Catatonia; Female; Flupenthixol; Humans; Psychom

2018
Diagnosis and management of periodic catatonia.
    Journal of psychiatry & neuroscience : JPN, 2013, Volume: 38, Issue:3

    Topics: Amantadine; Antipsychotic Agents; Catatonia; Humans; Male; Middle Aged; Periodicity; Recurrence

2013
Combined use of electroconvulsive therapy and amantadine in adolescent catatonia precipitated by cyber-bullying.
    Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:3

    Topics: Adolescent; Amantadine; Bullying; Catatonia; Combined Modality Therapy; Dopamine Agents; Electroconv

2013
Catatonia and parkinsonism as a sequelae of typhoid fever: a rare experience.
    BMJ case reports, 2013, Jun-27, Volume: 2013

    Topics: Adolescent; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Benzothiazoles;

2013
Successful treatment of catatonia in a young man with schizophrenia and progressive diffuse cerebral atrophy.
    The Journal of neuropsychiatry and clinical neurosciences, 2014,Winter, Volume: 26, Issue:1

    Topics: Adolescent; Amantadine; Anticonvulsants; Antiparkinson Agents; Antipsychotic Agents; Atrophy; Catato

2014
Excellent response to amantadine in a patient with bipolar disorder and catatonia.
    The Journal of neuropsychiatry and clinical neurosciences, 2014,Winter, Volume: 26, Issue:1

    Topics: Amantadine; Bipolar Disorder; Catatonia; Dopamine Agents; Female; Humans; Middle Aged

2014
Resistant Catatonia in a High-Functioning Autism Spectrum Disorder Patient Successfully Treated with Amantadine.
    Journal of child and adolescent psychopharmacology, 2015, Volume: 25, Issue:9

    Topics: Adult; Amantadine; Autism Spectrum Disorder; Catatonia; Drug Resistance; Humans; Male; Receptors, N-

2015
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.
    Neurocase, 2010, Volume: 16, Issue:5

    Topics: Aged; Amantadine; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Catatonia; Citalopram; Clinica

2010
Westphal variant Huntington disease and refractory catatonia: a case report.
    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2011, Volume: 24, Issue:4

    Topics: Adult; Amantadine; Carbidopa; Catatonia; Combined Modality Therapy; Dopamine Agents; Drug Combinatio

2011
Short-term treatment of catatonia with amantadine in schizophrenia and schizoaffective disorder.
    Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:4

    Topics: Adult; Amantadine; Catatonia; Female; Humans; Male; Psychotic Disorders; Receptors, N-Methyl-D-Aspar

2012
A case of catatonia in a 14-year-old girl with schizophrenia treated with electroconvulsive therapy.
    Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, 2013, Volume: 41, Issue:1

    Topics: Adolescent; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Comb

2013
Amantadine in catatonia due to major depressive disorder in a medically ill patient.
    The Journal of neuropsychiatry and clinical neurosciences, 2007,Fall, Volume: 19, Issue:4

    Topics: Adult; Amantadine; Antiparkinson Agents; Catatonia; Depressive Disorder, Major; Electroconvulsive Th

2007
Treatments for neuroleptic malignant syndrome.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:3

    Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Catatonia; Electroconvulsive Therapy; Fever;

1984
Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine.
    Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:4

    Topics: Adult; Amantadine; Catatonia; Glutamic Acid; Humans; Infusions, Intravenous; Male; N-Methylaspartate

1997
Therapeutic efficacy of N-methyl D-aspartate antagonist amantadine in febrile catatonia.
    Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:5

    Topics: Adult; Amantadine; Bipolar Disorder; Catatonia; Dopamine Agents; Excitatory Amino Acid Agonists; Fev

1999
Potentiation of anticatatonic effect of antidepressants by amantadine.
    The Indian journal of medical research, 1977, Volume: 66, Issue:1

    Topics: Amantadine; Animals; Antidepressive Agents; Biogenic Amines; Brain Chemistry; Catatonia; Drug Synerg

1977
Catatonic reactions to high-potency neuroleptic drugs.
    Archives of general psychiatry, 1977, Volume: 34, Issue:8

    Topics: Adolescent; Adult; Amantadine; Catatonia; Dose-Response Relationship, Drug; Female; Fluphenazine; Ha

1977
[Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1973, Volume: 73, Issue:8

    Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Catatonia; Chlorpromazine; Facial Mus

1973
Comparative effects of apomorphine, piribedil and other neurotropic agents on central analgesic-induced catatonia in the rat.
    European journal of pharmacology, 1974, Volume: 29, Issue:1

    Topics: Amantadine; Analgesics, Opioid; Animals; Antiparkinson Agents; Apomorphine; Atropine; Benserazide; B

1974
[Pharmacological study of amantadine, a new antiparkinson drug].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1974, Volume: 70, Issue:1

    Topics: Amantadine; Amines; Animals; Antiparkinson Agents; Avoidance Learning; Brain; Catatonia; Dopamine; D

1974